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Nrf2 deficiency improves autoimmune nephritis caused by the
fas mutation lpr.
Background. Nrf2 is a basic leucine zipper transcriptional ac-
tivator essential for the coordinate transcriptional induction of
antioxidant and phase II drug metabolizing enzymes. We previ-
ously reported that Nrf2-deficient female mice develop lupus-
like autoimmune nephritis (Kidney Int 60:1343–1353, 2001). The
result suggested that nrf2 is a possible candidate gene in deter-
mining susceptibility to autoimmune diseases. MRL/lpr mice,
defective in Fas-mediated apoptosis, develop glomerulonephri-
tis due to the production of autoantibodies.
Methods. To investigate the mechanism whereby Nrf2 con-
tributes to the susceptibility to autoimmune diseases, we gener-
ated nrf2 −/− lpr/lpr mice.
Results. Unexpectedly, the lifespan of nrf2 −/− lpr/lpr fe-
male mice was markedly prolonged and these mice showed
an improvement in nephritis compared to nrf2+/+ lpr/lpr fe-
male mice. Immunologic abnormalities and hypergammaglob-
ulinemia were also alleviated in nrf2−/− lpr/lpr female mice.
Furthermore, lymphadenopathy was suppressed as a result of
increased apoptosis. To elucidate the molecular mechanism
causing a stimulation of apoptosis, we analyzed the response
made by nrf2 −/− lpr/lpr mice to death signals. We show that
nrf2−/− lpr/lpr mice are sensitive to tumor necrosis factor-a
(TNF-a)–mediated apoptosis. Since intracellular glutathione
levels are decreased in Nrf2-deficient cells, it is probable that a
prolonged depletion in glutathione levels leads to the enhance-
ment in TNF-a–mediated apoptosis.
Conclusion. These results indicate that a deficiency in Nrf2
enhances TNF-a–mediated apoptosis which in-turn ameliorates
the abnormal apoptotic response that arises from a mutation in
the lpr gene. Therefore, Nrf2 deficiency acts as a suppressor of
the autoimmune accelerating gene lpr.
Nrf2 [nuclear factor-erythroid 2 (NF-E2–related factor
2)] is a basic leucine zipper (b-Zip) transcriptional acti-
vator, originally identified as a protein capable of bind-
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ing the NF-E2 promoter element [1, 2]. Nrf2 is essential
for the coordinate transcriptional induction of antioxi-
dant and phase II drug metabolizing enzymes through the
antioxidant response element/electrophile response ele-
ment (ARE/EpRE) [3, 4]. The ARE/EpRE sequence has
been identified within the proximal regulatory sequences
of antioxidant genes encoding glutathione S-transferase
(GST) [5], NAD(P)H quinine oxidoreductase (NQO1)
[6], heme oxygenase-1 (HO-1) [7], c-glutamylcysteine
synthetase [8], and cystine membrane transporter (sys-
tem Xc−) [9]. The ARE also regulates a wide range of
metabolic responses to oxidative stress caused by reactive
oxygen species (ROS) or electrophiles [9]. Understand-
ably, targeted disruption of the nrf2 gene in mice renders
the animals sensitive to high levels of oxidative stress due
to impairment in this stress response system [9–11].
We previously reported that aged Nrf2-deficient
female mice presented with several immunopatho-
logic features characteristic of human lupus, including
splenomegaly, proteinuria, production of antinuclear an-
tibodies, mesangial and capillary immune complex depo-
sition with subsequent proliferative or crescentic change
within glomeruli, and, eventually, renal failure and death
[12]. These findings indicate a role for oxidative stress
in the development of lupus, and also point to nrf2 as
a possible candidate gene in determining susceptibil-
ity to autoimmune diseases. A number of lupus mod-
els and mouse strains have been established and studied
extensively with respect to disease pathogenesis, in-
cluding MRL/Mp-lpr/lpr (MRL/lpr) [13], BXSB/MpJYaa
[13], and NZB/NZW F1 [14, 15]. However, linkage of the
nrf2 gene to any of these lupus strains has not been de-
scribed previously. MRL/lpr mice spontaneously develop
lymphadenopathy and an autoimmune disorder charac-
terized by immune complex glomerulonephritis, arthritis,
vasculitis, and antinuclear antibodies [13]. The predomi-
nant cell type that occupies the lymphoid organ are phe-
notypically double negative (CD4−CD8−) with respect
to T-cell surface markers. These cells also possess the
B220 cell surface marker usually restricted to B cells. The
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double negative T cells also display hallmarks of ma-
ture T lymphocytes, including CD3 and the ab-TCR [13].
The genetic defect that leads to lymphoproliferation (lpr)
is a mutation in the gene coding Fas [16], a cell sur-
face molecule that belongs to the tumor necrosis factor
(TNF) receptor gene family. The development of lym-
phadenopathy and of autoimmune disease in lpr mice
has been attributed to a defect in Fas-mediated apopto-
sis causing a failure in the activation-induced cell death
of activated T cells [16, 17]. Thus, the lpr gene is be-
lieved to be the fundamental molecular abnormality in
MRL/lpr mice. However, the spectrum of autoimmune
manifestations is greatly affected by the host genetic
background. For example, when the lpr is crossed on to
the MRL/Mp strain, the disease is markedly accelerated,
and most mice die by 6 months of age [18]. Whereas,
MRL/lpr, lpr congenic mice of the C3H/HeJ, AKR or
C57BL/6 background rarely develop nephritis or vasculi-
tis [19–21]. These results indicate that the development
of autoimmune diseases in MRL/lpr mice requires both
an accelerating gene (lpr) and susceptibility genes (genes
specific to the genetic background).
To further define the mechanism whereby Nrf2 de-
termines the susceptibility to autoimmune diseases, we
generated nrf2−/− lpr/lpr female mice and estimated the
survival rate and the development of glomerulonephritis.
Unexpectedly, nrf2−/− lpr/lpr female mice had a sig-
nificantly longer lifespan and less severe nephritis than
nrf2+/+ lpr/lpr female mice. Detailed analyses revealed
that, in lpr mice, a deficiency in Nrf2 enhanced the sensi-
tivity of TNF-a–mediated apoptosis and suppressed the
autoimmune acceleration effect of the lpr gene. These
results demonstrate that Nrf2 deficiency may act as sup-
pressor of the autoimmune accelerating gene lpr, instead
of being a susceptibility gene in these mice.
METHODS
Generation of nrf2 mutant lpr mice
The generation of Nrf2-deficient mice was previously
described [4]. Genotypes of homozygous wild-type and
Nrf2-deficient mice were confirmed by polymerase chain
reaction (PCR) amplification of genomic DNA isolated
from tails. PCR amplification was carried out by using
three different primers, 5′-TGGACGGGACTATTGAA
GGCTG-3′ (sense for both genotypes), 5′-CGCCTTTT
CAGTAGATGGAGG-3′ (antisense for wild-type),
and 5′-GCGGATTGACCGTAATGGGATAGG-3′ (an-
tisense for LacZ). MRL/lpr mice were obtained from
Japan SLC (Shizuoka, Japan). Intercrossing Nrf2-
deficient mice with an ICR background and MRL/lpr
mice generated nrf2−/− lpr/lpr mice and control nrf2+/+
lpr/lpr mice. The present study utilized female mice from
the same litters. Mice were maintained in the Labora-
tory Animal Resource Center. All experiments were per-
formed according to the Guide for the Care and Use of
Laboratory Animals in University of Tsukuba.
Measurement of urinary protein, serum creatinine, and
blood urea nitrogen
The urine of each mouse was collected in individual
metabolic cages over a 24-hour period from nrf2−/−
lpr/lpr and nrf2+/+ lpr/lpr 20-week-old female mice. The
amount of proteinuria was assessed by measuring the tur-
bidity obtained with 3% sulphosalicylic acid. Protein val-
ues more than 2 mg/24 hours were considered abnormal.
The concentration of serum creatinine and blood urea ni-
trogen (BUN) were measured by an automated analyzer
for routine laboratory tests (Dry-Chem 3500) (Fuji Film,
Inc., Tokyo, Japan).
Histopathologic analysis of renal tissues
Each mouse was bled while under ether anesthesia.
Sera were stored at −80◦C until use. At autopsy, organs
were fixed with 10% formalin in 0.01 mol/L phosphate
buffer (pH 7.2) and embedded in paraffin. Sections were
stained with hematoxylin and eosin for histopathologic
examination under light microscopy. For semiquantita-
tive histologic analysis, more than 20 glomeruli from each
kidney section were examined. The degree of glomeru-
lar lesion was estimated using a scale of 0 to 3 based on
the severity and extent of histopathologic changes, as de-
scribed previously [19]. The index of glomerular lesion
is the mean value of more than 20 observed glomeruli.
Sections frozen for immunofluorescent analysis were
stained using fluorescein isothiocyanate (FITC)-labeled
antimouse IgG, IgG1, IgG2a, IgG3, IgM, and C3 (ICN
Pharmaceuticals, Inc., Aurora, OH, USA). Quantitative
estimation of immunofluorescent staining was performed
using ImageJ (National Institutes of Health, Bethesda,
MD, USA). Relative fluorescent intensity was described
as the mean fluorescent intensity of nrf2+/+ lpr/lpr mice
equals 1.0.
Immunohistochemical examination
Kidneys that were to be used for immunoperoxidase
staining were snap-frozen in optimal cutting tempera-
ture (OCT) (Miles Scientific, Naperville, IL, USA) and
stored at −80◦C. We identified macrophage (F4/80),
CD4-, CD8-, and B220-positive cells using monoclonal
antibodies as described by Iwata et al [22]. Anti-CD4,
CD8, and B220 antibodies were purchased from BD Bio-
sciences (San Jose, CA, USA) and anti-F4/80 antibody
from Serotec (Oxford, UK). These cells were identified
by avidin-biotin complex immunoperoxidase technique
using Histofine Kit (Nichirei, Tokyo, Japan). We counted
macrophage, CD4-, CD8-, and B220-positive cells in
periglomerular areas of 10 randomly selected glomeruli
Morito et al: Nrf2 deficiency prevents Fas-mediated autoimmune diseases 1705
and have expressed the results as cells/glomerulus. Inter-
stitial CD4-, CD8-positive T cells and B220-positive cells
were counted in 10 randomly selected fields of cortical in-
terstitium using a light microscope (magnification, ×400)
and described as/fields.
Cytokine expression
We evaluated renal colony stimulating factor 1
(CSF-1), monocyte chemoattractant protein 1 (MCP-1),
TNF-a, transforming growth factor 1 (TGF-b1) and in-
terferon c (IFN-c) transcripts by reverse transcription-
polymerase chain reaction (RT-PCR) method. Total
RNA was extracted from the kidney using TRIzol (In-
vitrogen, Carlsbad, CA, USA). RT was performed us-
ing the SuperScript First-Stranded Synthesis System for
RT-PCR (Invitrogen). The complementary DNA product
was amplified by PCR. Primers (CSF-1, 5′ primer AAA
GCCACTCTTGGGGCATT, 3′ primer TCGATGGCT
CCACTTCC; MCP-1, 5′ primer AGCAGGTGTCCCA
AAGAAGC, 3′ primer ACAAAGTTTACCCATTCA
TC; TNF-a 5′ primer AGGTTCTCTTCAAGGGAC
AA, 3′ primer TCACAGAGCAATGACTCCAA; TGF-
b1, 5′ primer GGACCTGGGTTGGAAGTGGA, 3′
primer GCGACCCACGTAGTAGACGA; IFN-c, 5′
primer CAAGTGGCATAGATGTGGAA, 3′ primer G
TTGTTGACCTCAAACTTGG; GAPDH, 5′ primer
CCCCTTCATTGACCTCAACTACATGG, 3′ primer
GCCTGCTTCACCACCTTCTTGATGTC) were used
for PCR. The housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used for PCR
controls.
Total glutathione (GSH) level of kidneys
Kidneys from nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr
20-week-old female mice were homogenized and sus-
pended in 5% sulfosalicylic acid. Subsequently, total GSH
level was measured by an enzyme recycling method us-
ing the Total Glutathione Quantification Kit (Dojindo,
Kumamoto, Japan).
Measurement of serum immunoglobulin
Serum immunoglobulin was determined by enzyme-
linked immunosorbent assay (ELISA) as previously de-
scribed [12]. Briefly, Nunc-Immunoplates (Nunc A/S,
Roskilde, Denmark) were coated with goat antimouse
immunoglobulin (ICN Pharmaceuticals, Inc.). The plates
were kept at room temperature for 1 hour and were
then washed with 0.1 mol/L phosphate-buffered saline
(PBS). After washing, the plates were blocked with 0.5%
bovine serum albumin (BSA) in a PBS solution. Serial
dilutions of test serum samples were applied and incu-
bated at room temperature for 1 hour. After washing with
PBS, the plates were treated with alkaline phosphatase-
conjugated goat antimouse IgM, IgG, IgG1,and IgG2a
(Sigma Chemical Co., St. Louis, MO, USA) at room
temperature for 1 hour. After additional washes, alka-
line phosphatase substrate (Sigma Chemical Co.) solu-
tion was added and allowed to develop. Absorption at
405 nm was measured using an immuno-plate reader
(BenchMark) (Bio-Rad, Hercules, CA, USA). In or-
der to measure IgG3 levels, single radial immunodiffu-
sion (SRID) was performed. One percent agalose gels in
0.1 mol/L PBS, pH7.2, which contained anti-Ig isotype
serum (rabbit antimouse IgG3), was purchased from
Miles Laboratories Inc. (Elkhart, IN, USA) were pre-
pared and spread on a glass plate. Samples (4 lL)
were applied to punched holes of 1.5 mm in diameter
and the slides were incubated at room temperature for
48 hours. Precipitation rings were measured after stain-
ing with AminoBlock 10B.
Anti-double-stranded DNA antibody assay
ELISA was used to determine the titer of anti-double
stranded DNA antibody in sera as described previously
[19]. Nunc-Immunoplates were coated with protamine
sulfate (Sigma Chemical Co.). Subsequently, a solution
of double-stranded DNA was added to the plates. The
double-standed DNA was prepared from calf thymus
DNA treated with S1 nuclease (Sigma Chemical Co.)
to eliminate single-stranded DNA according to the pub-
lished method [23]. The plates were kept at 4◦C overnight
and then washed with PBS. Afterward, the plates were
blocked with 0.5% BSA in PBS solution. Serial dilutions
of test serum samples were added and incubated at room
temperature for 1 hour. After washing with PBS, the
plate was treated with alkaline phosphatase-conjugated
goat antimouse IgG (Sigma Chemical Co.) and pro-
cessed as described previously in this article. The titer
of anti-double-stranded DNA antibodies in pooled sera
from four 20-week-old MRL/lpr female mice was set at
100 units.
Lymphadenopathy scoring
Arbitrary clinical scoring of lymphnodes was assigned
by an observer blinded to group identities, using a scale of
0–4 (0 = none; 1 = a single node anywhere; 2 = bilateral
axillary; 3 = femoral, or cervical nodes; and 4 = massive
generalized adenopathy) [24].
Fluorescence-activated cell sorter (FACS) analysis
Single-cell suspensions were prepared from the lym-
phnodes of each mouse and blocked with anti-FccR
antibody (2.4G2) for 10 minutes on ice to inhibit the
interaction of staining reagents with the cell surface.
Multicolor flow cytometry analysis was performed us-
ing LSR and Cellquest software (Becton Dickinson,
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Franklin Lakes, NJ, USA) on viable cells as deter-
mined by forward light scatter intensity and propid-
ium iodide exclusion. The following phycoerythrin (PE),
FITC, or peridinin chlorophyll protein (perCP)-labeled
monoclonal antibodies were used: anti-CD4-PE, anti-
CD8-FITC, anti-CD3-perCP (BD Biosciences) and anti
F4/80-PE (Serotec). Bilateral cervical and axillary lym-
phnodes were obtained from nrf2−/− lpr/lpr and nrf2+/+
lpr/lpr mice. Total cell numbers of each lymphocytes and
macrophages were counted.
Terminal deoxynucleotidyl transferase (TdT) nick
end-labeling (TUNEL) assay
Apoptotic cells were estimated by the TUNEL as-
say, which relies on incorporation of labeled deoxyuri-
dine triposphate (dUTP) at sites of DNA breaks. For the
TUNEL procedure, all reagents, including buffer, were
part of a kit (In situ Takara Apoptosis Kit; Takara, Inc.,
Otsu, Japan). Procedures were carried out according to
the manufacturer’s instructions. Apoptosis was examined
in 5 lm thick sections of the spleens, kidneys, and livers
of nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr mice. For quan-
titative histologic analysis, the degree of apoptosis was
estimated using a scale based on the mean number of
TUNEL-positive cells per 20 microscopic fields, or per
field (magnification, ×400).
Induction of splenocyte apoptosis by TNF-a
Splenocytes were isolated from 8-week-old nrf2−/−
lpr/lpr and nrf2+/+ lpr/lpr mice. The cells were washed
in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% heat-inactivated fetal bovine serum
(FBS), 0.5 mmol/L 2-mercaptoethanol, 2 mmol/L glu-
tamine, 1 mmol/L N-2-hydroxyethylpiperazine-N′−2-
ethanesulfonic acid (HEPES) (pH 7.4) and antibiotics
(all from Invitrogen Inc.). The cells were again washed
in medium before use in subsequent tissue culture ex-
periments. The cells (1 × 106/mL) were incubated with
various concentrations of TNF-a for 12 hours. TNF-a
was purchased from BD Biosciences. Cell viability was
determined by trypan blue exclusion. The cells were pre-
incubated with glutathione ethyl monoester (GSH-OEt)
(2 mmol/L for 15 to 20 minutes) to increase the intracel-
lular pool of GSH. GSH-OEt was obtained from Wako
(Osaka, Japan).
Hepatocellular apoptosis induction by administration
of anti-Fas antibody and TNF-a in mice
Agonistic antimouse Fas antibody (Jo-2) (BD Bio-
sciences) (2 mg/mouse) was administered to 20-week-old
female mice intraperitoneally in sterile saline solu-
tion. Human recombinant TNF-a (BD Biosciences)
(0.5mg/mouse) was also administered intraperitoneally.
To increase the TNF-a sensitivity, D-galactosamine hy-
drochloride (GalN) (Nacalai Tesque, Tokyo, Japan) was
preinjected intravenously 30 minutes before TNF-a injec-
tion. To assess the importance of the intracellular GSH
level, GSH-OEt (20 mg/mouse) was preinjected intra-
venously 2 hours before TNF-a injection and the same
experiments performed. Hepatocellular injury was mon-
itored biochemically by measuring serum alanine amino-
transferase (ALT) activity using an automated analyzer
(Dry-Chem 3500) (Fuji Film). At the end of the experi-
mental period mice were sacrificed for necropsy. The liver
was excised, fixed with 10% buffered formalin, sectioned
at a thickness of 5 lm, and stained with hematoxylin and
eosin for examination by light microscope.
Statistical analysis
Results were expressed as means ±SEM. Multiple data
comparisons were performed using the one-way analy-
sis of variance (ANOVA) routinely with the Bonferroni
correction. Significant differences between the groups of
mice were analyzed using the Wilcoxon test for paired
samples, and P values less than 0.05 were considered sta-
tistically significant. Comparisons of survival rate were
done by the Kaplan-Meier method.
RESULTS
Survival rate
nrf2−/− lpr/lpr female mice had a markedly prolonged
lifespan with 50% of the mice having survival times twice
as long as nrf2+/+ lpr/lpr female mice (Fig. 1). The 50%
survival weeks of nrf2−/− lpr/lpr female mice were 45.4 ±
2.2 weeks in comparison to 23.2 ± 6.1 weeks for the
nrf2+/+ lpr/lpr female mice. The 50% survival weeks of
MRL/lpr mice was 6 months [18], which was almost the
same as that of nrf2+/+ lpr/lpr mice.
Renal function and urinary protein
MRL/lpr mice are known to die from renal failure
caused by autoimmune kidney disease [13]. We evalu-
ated renal function in nrf2−/− lpr/lpr mice by measuring
serum creatinine and BUN, as an index of renal function,
in a time series experiment. The levels of serum creati-
nine and BUN were decreased in nrf2−/− lpr/lpr mice
compared to nrf2+/+ lpr/lpr mice at 20 weeks old, but
only significantly in the case of BUN levels. We also per-
formed other studies, including urinary protein analysis,
at 20 weeks of age (Table 1). The urinary protein levels
of nrf2−/− lpr/lpr female mice were significantly lower
than that of nrf2+/+ lpr/lpr female mice at 20 weeks of
age.
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Fig. 1. Survival rate and renal function of lpr female mice. (A) Sur-
vival rate of nrf2−/− lpr/lpr (N = 20) and nrf2+/+ lpr/lpr (N = 20)
female mice using Kaplan-Meier method. The difference in survival
rate between nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr mice was significant
(P < 0.05). (B) Serum creatinine (CRE) and blood urea nitrogen (BUN)
were decreased in nrf2−/− lpr/lpr mice (N = 10) compared to nrf2+/+
lpr/lpr mice (N = 10) at 20 weeks old, but only BUN showed a significant
decrease (∗P < 0.05) (serum creatinine, P = 0.08). Each bar represents
the mean± SEM.
Table 1. Clinical and serologic manifestations in nrf2 −/− lpr/lpr and
nrf2 +/+ lpr/lpr female mice at 20 weeks of agea
nrf2 −/− lpr/lpr N nrf2 +/+ lpr/lpr N P value
Urinary protein 1.2 ± 0.3 15 3.6 ± 1.0 16 <0.05
mg/day
IgM mg/dL 469.4 ± 52.1 10 624.9 ± 111.2 10 NS
IgG mg/dL 2821.5 ± 353.1 10 8526.1 ± 788.9 10 <0.05
IgG1 mg/dL 199.8 ± 35.1 10 524.3 ± 88.4 10 <0.05
IgG2a mg/dL 1815.2 ± 318.4 10 6226.7 ± 1475.0 10 <0.05
IgG3 mg/dL 651.2 ± 86.3 10 913.4 ± 104.2 10 NS
Anti-dsDNA 31.5 ± 10.3 10 103.3 ± 22.7 10 <0.05
IgG units
Lymphadenopathy 0.9 ± 0.3 20 1.5 ± 0.5 20 <0.05
scoreb
ds DNA is double-stranded DNA.
aResults are shown as means ± SEM; bUsing a scale of 0 to 4 described in the
Methods section.
Histologic analysis
Renal histopathologic studies were performed in
nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr female mice at
20 weeks of age. In nrf2+/+ lpr/lpr female mice, glomeru-
lonephritis with inflammation, sclerosis, and crescent for-
mation were observed (Fig. 2A). By contrast, glomerular
lesions were improved in nrf2−/− lpr/lpr female mice
(Fig. 2B). The average of indices of glomerular lesions
(as described in the Methods section) in nrf2+/+ lpr/lpr
and nrf2−/− lpr/lpr female mice were 2.8 ± 0.3 (N = 10)
and 2.0 ± 0.2 (N = 10), respectively (P < 0.05). IgG, IgM,
and C3 deposits were observed by immunofluorescence
staining in the kidney of both nrf2−/− lpr/lpr and nrf2+/+
lpr/lpr mice. IgG and C3 deposits in the mesangial re-
gions and the capillary walls of glomeruli were decreased
in nrf2−/− lpr/lpr mice compared to nrf2+/+ lpr/lpr mice
(P < 0.05). From the isotype staining of IgG, IgG2a and
IgG3 deposits were found to be decreased in nrf2−/−
lpr/lpr mice compared to nrf2+/+ lpr/lpr mice, signifi-
cantly (P < 0.05) (Fig. 2C and D).
Immunohistochemical examination
Abnormal renal function in MRL/lpr mice consists of
leukocyte infiltration, including macrophage, CD4 and
CD8 T cells, and B220-positive cells [22]. We evaluated
the numbers of these infiltrates in the glomeruli and in-
terstitium nrf2−/− lpr/lpr kidneys at 20 weeks old. The
numbers of macrophage (F4/80), CD4, CD8-positive T
cells, and B220-positive cells were significantly reduced
in nrf2−/− lpr/lpr kidneys compared with nrf2+/+ lpr/lpr
kidneys (Fig. 3A and B). It has been reported that B220-
positive cells in the kidney are unique double negative
T cells and are not B cells in MRL/lpr mice [25, 26].
This result suggests that the reduction in numbers of
macrophages, CD4, CD8-positive and double-negative T
cells would lead to an improvement of kidney disease in
nrf2−/− lpr/lpr mice.
Influence of nrf2 −/− on the level of key cytokines
It was previously reported that CSF-1, MCP-1, TNF-a,
TGF-b1, and IFN-c transcripts are up-regulated with the
onset of renal injury in MRL/lpr mice and are a causative
factor in the progression of autoimmune kidney disease
[27–31]. So we determined these cytokines transcript lev-
els by RT-PCR method. In nrf2−/− lpr/lpr kidneys, CSF-
1, MCP-1, TNF-a, TGF-b1, and IFN-c transcripts were
reduced compared to nrf2+/+ lpr/lpr kidneys. (Fig. 3C).
Level of GSH in renal tissue
It has previously been described that various antioxi-
dant and detoxification enzymes which are subject to Nrf2
regulation are reduced in the liver and macrophages of
Nrf2-deficient mice [5–9]. As a consequence, Nrf2 defi-
ciency may lead to high levels of oxidative stress and a
depletion of GSH synthetic enzymes. We hypothesized
that a reduction in GSH in renal tissue could influence
the pathogenesis of autoimmune kidney disease. There-
fore we measured renal GSH levels in nrf2−/− lpr/lpr
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Fig. 2. Histopathologic analysis of renal tis-
sues in nrf2−/− lpr/lpr mice. Renal sec-
tion from an nrf2−/− lpr/lpr 20-week-old fe-
male mouse (B) showed the improvement
of glomerular lesions compared to an age-
matched nrf2 +/+ lpr/lpr mouse (A) (×100,
hematoxylin and eosin stain). Immunofluo-
rescent staining of IgG, IgM, C3, IgG1, IgG2a,
and IgG3 (C). IgG, IgG2a, IgG3, and C3 de-
posits in the mesangial regions and the cap-
illary walls of glomeruli were decreased in
nrf2−/− lpr/lpr mice compared to nrf2+/+
lpr/lpr mice (×400). Quantitative analysis
of immunofluorescent stainig revealed IgG,
IgG2a, IgG3, and C3 deposits were signifi-
cantly decreased in nrf2−/− lpr/lpr mice (D)
(∗P < 0.05). Each bar represents the mean ±
SEM.
mice. Renal GSH was significantly reduced in nrf2−/−
lpr/lpr mice compared to nrf2+/+ lpr/lpr mice (Fig. 3D).
Serum immunoglobulin and anti-double-stranded
DNA antibodies
To evaluate immunologic abnormalities, the serum im-
munoglobulins in nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr
female mice at 20 weeks of age were measured. There
was no significant difference in serum IgM levels be-
tween nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr female mice
(Table 1). Serum IgG levels of nrf2−/− lpr/lpr were lower
than those of nrf2+/+ lpr/lpr female mice. Serum im-
munoglobulin levels of nrf2+/+ lpr/lpr female mice were
almost comparable to those of MRL/lpr female mice as
previously described [32]. The levels of IgG, IgG1, and
IgG2a were also decreased in nrf2−/− lpr/lpr female
mice compared to nrf2+/+ lpr/lpr female mice (Table 1).
Serum IgG3 level in nrf2−/− lpr/lpr was also lower than
nrf2+/+ lpr/lpr mice, but not significantly. There was
not a significant difference in serum IgG3 level between
nrf2−/− lpr/lpr and nrf2+/+ lpr/lpr mice. However, in
immunofluorescence staining, IgG3 deposition was de-
creased in nrf2−/− lpr/lpr mice compared to nrf2+/+
lpr/lpr mice. This result suggests IgG3 is one of the major
factors responsible for the development of glomeru-
lonephritis in lpr/lpr mice. The production of anti-double-
stranded DNA autoantibody was significantly reduced in
nrf2−/− lpr/lpr female mice when compared to nrf2+/+
lpr/lpr female mice (P < 0.05) (Table 1). Since the amount
of anti-double-stranded DNA autoantibody in pooled
sera from 20-week-old MRL/lpr female mice was set
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Fig. 3. Renal profile of infiltrated leuko-
cytes and macrophages, key cytokines, and
glutathione (GSH) levels. The numbers of
macrophage (F4/80), CD4, CD8-positive T
cells, and B220 positive cells were signifi-
cantly reduced in the glomeruli and inter-
stitium of nrf2−/− lpr/lpr kidneys compared
with nrf2+/+ lpr/lpr kidneys in immunohis-
tochemical examination (A and B). Colony
stimulating factor 1 (CSF-1), monocyte
chemoattractant protein 1 (MCP-1), tu-
mor necrosis factor-a (TNF-a), transforming
growth factor-b1 (TGF-b1), and interferon c
(IFN-c) levels were reduced in nrf2−/− lpr/lpr
kidneys compared to nrf2+/+ lpr/lpr kidneys
[reverse transcription-polymerase chain reac-
tion (RT-PCR) method] (C). Renal GSH was
significantly reduced in nrf2−/− lpr/lpr mice
compared to nrf2+/+ lpr/lpr mice (D). Each
bar represents the mean ± SEM. ∗P < 0.05.
at 100 units, the titer of anti-double-stranded DNA au-
toantibody in nrf2+/+ lpr/lpr female mice was equal to
MRL/lpr female mice.
Lymphadenopathy scoring
MRL/lpr mice develop massive lymphadenopathy due
to a defect in Fas [16]. Therefore, lymphadenopathy in
nrf2−/− lpr/lpr mice was evaluated. The scoring of lym-
phadenopathy was assigned by an observer, as described
in the Methods section. The average score value was de-
creased in nrf2−/− lpr/lpr mice (Table 1).
FACS analysis of lymph nodes
We found lymphadenopathy was improved in nrf2−/−
lpr/lpr mice. Next, we performed FACS analysis to exam-
ine the subset of lymphocytes and macrophages in lymph
nodes. The numbers of CD4, CD8-positive, double-
negative T cells and macrophage (F4/80) was significantly
reduced in nrf2−/− lpr/lpr lymph nodes compared with
nrf2+/+ lpr/lpr lymph nodes (Fig. 4).
TUNEL assay of spleen and kidney
Since Fas-mediated apoptosis is defective in lpr mice,
the immunologic improvements seen in nrf2−/− lpr/lpr
mice suggested that the activity of Nrf2 might somehow
be linked to Fas-mediated apoptosis. Therefore, apop-
tosis in spleen and kidney was examined. The indices
of TUNEL-positive cells were significantly increased in
nrf2−/− lpr/lpr mice compared to nrf2+/+ lpr/lpr mice
(Fig. 5). We observed apoptosis was increased in nrf2−/−
lpr/lpr spleens and kidneys.
Induction of TNF-a–mediated apoptosis in splenocytes
We examined the effect of apoptosis triggered by
anti-Fas antibody in splenocytes obtained from nrf2−/−
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Fig. 4. Lymphocytes and macrophages in nrf2−/− lpr/lpr and
nrf2+/+ lpr/lpr mice lymphnodes. Twenty-week-old nrf2−/− lpr/lpr
(N = 4) and nrf2+/+ lpr/lpr (N = 4) female mice were used for
fluorescence-activated cell sorter (FACS) analysis. Each bar represents
the mean ± SEM. ∗P < 0.05.
lpr/lpr mice. However, there were no difference in apop-
totic splenocytes between from nrf2−/− lpr/lpr mice and
nrf2+/+ lpr/lpr mice (data not shown). This result sug-
gested that the immunologic improvements in nrf2−/−
lpr/lpr mice were not due to an enhancement of Fas-
mediated apoptosis. Fas and TNF receptor I (TNF-RI)
share homology in their cytoplasmic death domain, a re-
gion important for apoptotic signaling [33]. It has been
reported that, in lpr mice lacking TNF-RI, autoimmu-
nity is greatly accelerated [34]. These facts indicate that
TNF-RI might play a compensatory role in Fas-mediated
apoptosis in lpr mice. Therefore, we examined the effect
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Fig. 5. Detection of apoptotic cells in the spleen of nrf2−/− lpr/lpr
mice by terminal deoxynucleotidyl transferase (TdT) nick end-labeling
(TUNEL) method. Using the TUNEL method, apoptosis was estimated
in the spleens and kidneys of 20-week-old lpr/lpr female mice. Each bar
represents the mean ± SEM. ∗P < 0.05.
of TNF-a on cultured splenocytes from nrf2−/− lpr/lpr
mice. We showed that the survival rate of splenocytes
from nrf2−/− lpr/lpr mice was decreased compared to
nrf2+/+ lpr/lpr mice (P < 0.05) (Fig. 6A). It has been
reported that prolonged GSH depletion enhances death
receptor (Fas, TNF-RI)−mediated apoptosis [35–37]. We
and others reported that intracellular GSH levels were re-
duced in Nrf2-deficient cells [8, 9]. Moreover, we have re-
ported Nrf2 deficiency increases the sensitivity to Fas and
TNF-RI through intracellular glutathione depletion [38].
Therefore, we suspected that the observed sensitivity of
TNF-a–mediated apoptosis in nrf2−/− lpr/lpr mice could
be due to a depletion of cellular GSH levels resulting from
a deficiency in Nrf2. GSH-OEt is a compound capable of
passing the cell membrane and up-regulating the intra-
cellular levels of GSH [39]. To prove the enhancement of
TNF-a–mediated apoptosis in splenocytes from nrf2 −/−
lpr/lpr mice was due to a decrease in intracellular GSH
levels, GSH-OEt was administrated before TNF-a ad-
ministration. The administration of GSH-OEt increased
the survival rate in nrf2−/− lpr/lpr mice (Fig. 6B). These
results indicate that Nrf2 deficiency can enhance the sen-
sitivity of TNF-a–mediated apoptosis through GSH de-
pletion in vitro.
Hepatocellular apoptosis induction by TNF-a
It is well known that the administration of TNF-a to
GalN-sensitized mice can induce fulminant hepatitis as a
result of TNF-a–mediated apoptosis [40]. GalN increases
the susceptibility of mice to hepatotoxicity and the lethal
effects of TNF-a [40]. The effect of hepatocellular apop-
tosis in vivo triggered by TNF-a in nrf2−/− lpr/lpr mice
was examined. Serum ALT activity was monitored as in-
dices of hepatotoxicity. We showed that serum ALT activ-
ity after TNF-a administration was significantly increased
(P < 0.05) in nrf2−/− lpr/lpr mice compared to nrf2+/+
lpr/lpr mice (Table 2).
Histopathologic examination also revealed that apop-
totic hepatocytes were increased in nrf2−/− lpr/lpr mice
(Fig. 6D) compared to nrf2+/+ lpr/lpr mice (Fig. 6C). To
confirm the enhancement of hepatitis in nrf2−/− lpr/lpr
mice was due to a decrease in intracellular GSH lev-
els, GSH-OEt was administrated before TNF-a injection.
The administration of GSH-OEt decreased the ALT ac-
tivity in nrf2−/− lpr/lpr mice (Table 2). Histopathologic
findings also demonstrated GSH-OEt addition rescued
nrf2−/− lpr/lpr mice from TNF-a–mediated hepatocel-
lular apoptosis (Fig. 6E). Moreover, we performed a
quantitative analysis of TUNEL-positive apoptotic cells
induced by TNF-a. The number of apoptotic hepato-
cytes after TNF-a treatment was significantly increased
in nrf2/−/−lpr/lpr mice (N = 4) compared to nrf2+/+
lpr/lpr mice (N = 4) (Fig. 6F). These results indicate that
Nrf2 deficiency can enhance the sensitivity of TNF-a–
mediated apoptosis through GSH depletion and that the
enhanced sensitivity of TNF-a–mediated apoptosis can
improve the immunologic abnormality seen in lpr mice.
DISCUSSION
We previously reported that nrf2 might be one of the
candidate genes in determining the susceptibility to au-
toimmune diseases [12]. MRL/lpr mice, having a defect
in the Fas molecule, develop spontaneous autoimmune
nephritis with generalized peripheral lymphadenopathy
[16]. We speculated that lpr could stimulate autoimmune
disease under conditions where the nrf2 gene had been
deleted. Unexpectedly, this study showed autoimmune
nephritis was improved in nrf2−/− lpr/lpr mice. Inter-
estingly, we observed that ablation of the nrf2 gene in
lpr mice restimulated apoptosis, a response normally
blocked as a result of a mutation in fas. Fas is expressed at
high levels in activated T cells and thought to be critically
involved in activation-induced apoptosis in T cells [17,
41–45]. The lymphadenopathy and autoimmune disease
seen in MRL/lpr mice has been attributed to a defect in
Fas-mediated apoptosis in which activated T cells do not
undergo activation-induced cell death. In this paper, we
clearly demonstrate that apoptotic cells were increased
in spleen and kidney in nrf2−/− lpr/lpr mice compared
with nrf2+/+ lpr/lpr mice (Fig. 5). The lpr gene consists of
a transposon insertion into the fas gene resulting in very
few Fas molecules being present on the cell surface [16].
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Fig. 6. nrf2−/− lpr/lpr mice enhanced tumor necrosis factor-a (TNF-a)–mediated apoptosis whereas administration of glutathione ethyl monoester
(GSH-OEt) rescued nrf2−/− lpr/lpr mice from TNF-a– mediated apoptosis. Effects of Nrf2 deficiency on cultured splenocytes treated with TNF-a.
(A) Survival rate of nrf2−/− lpr/lpr splenocytes after TNF-a stimulation. Each bar represents the mean ± SEM. ∗P < 0.05. (B) GSH-OEt protected
nrf2−/− lpr/lpr splenocytes against TNF-a–mediated apoptosis. Splenocytes were pre-incubated with 2mM GSH-OEt. (C) Liver section from nrf
+/+ lpr/lpr mouse (×400, hematoxylin and eosin stain). (D) nrf2 −/− lpr/lpr mouse. Arrows indicate apoptotic nuclei (×400). (E) nrf2−/− lpr/lpr
mouse administered GSH-OEt. The number of apoptotic cells was decreased with GSH-OEt administration (×400). (F) Quantitative analysis of
terminal deoxynucleotidyl transferase (TdT) nick end-labeling (TUNEL)-positive apoptotic hepatocytes by TNF-a. Each bar represents the mean
± SEM. ∗P < 0.05.
Therefore, it was possible that the observed improve-
ment of apoptosis in nrf2−/− lpr/lpr mice could be due
to enhanced sensitivity of Fas-mediated apoptosis. How-
ever, the administration of anti-Fas antibody to nrf2−/−
lpr/lpr splenocytes had no stimulatory effect on apoptosis
(data not shown). A further reason for the immunologic
improvement seen in the nrf2−/− lpr/lpr mice may be
a modulation in TNF receptor signaling. Accumulating
evidence indicates that TNF signaling is also important
for apoptosis. Fas and TNF-RI share a region of homol-
ogy within their cytoplasmic portions called the death
domain, which is responsible for the delivery of intercel-
lular death inducing signals [33]. It has been reported that,
in lpr mice, substantial numbers of T cells still undergo
apoptosis, even though Fas-mediated apoptosis is defec-
tive [46]. Further studies have shown that in lpr mice lack-
ing TNF-RI, the development of lymphadenopathy and
autoantibody production was greatly accelerated com-
pared with TNF-RI wild-type lpr mice [34]. These mice
also exhibited high mortality and early onset autoimmune
disease characterized by massive mononuclear cell infil-
tration in liver, kidney, lung, and knee joints [34]. These
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Table 2. Hepatotoxicity and lethal effect in nrf2 −/− lpr/lpr mice induced by tumor necrosis factor-a (TNF-a)a
ALT(IU/L) Survival rateb
Treatment Time hours nrf2 −/− lpr/lpr nrf2 +/+ lpr/lpr nrf2 −/− lpr/lpr nrf2 +/+ lpr/lpr
GSH-OEt(−) TNF-a 0 26.8 ± 3.3 25.2 ± 3.9 5/5 5/5
GSH-OEt(−) TNF-a 4 761.4 ± 140.0c 192.0 ± 45.5 5/5 5/5
GSH-OEt(−) TNF-a 8 7110.3 ± 882.9c 1560.3 ± 145.4 4/5 5/5
GSH-OEt(−) TNF-a 12 9767.8 ± 867.3c 2850.1 ± 348.2 3/5 4/5
GSH-OEt(+) TNF-a 0 34.2 ± 4.2 28.8 ± 3.7 5/5 5/5
GSH-OEt(+) TNF-a 4 261.1 ± 55.7 143.8 ± 32.2 5/5 5/5
GSH-OEt(+) TNF-a 8 1230.3 ± 42.0 925.1 ± 199.6 5/5 5/5
GSH-OEt(+) TNF-a 12 2565.3 ± 234.8 1235.7 ± 129.8 5/5 5/5
Abbreviations are: ALT, alanine aminotransferase; GSH-OEt, glutathione ethyl monoester; TNF-a, tumor necrosis factor-a.
aResults are shown as mean ± SEM for three to five mice; bSurvival rate indicates the number of survived/all mice; cP < 0.05.
facts indicate that in lpr mice the defects in Fas-mediated
apoptosis are exacerbated in the absence of TNF-RI and
that normal expression of TNF-RI might partially com-
pensate for the Fas-mediated apoptosis defect of lympho-
cytes in lpr mice. In this study, we demonstrate that Nrf2
deficiency enhanced the sensitivity of TNF-a–mediated
apoptosis. Accordingly, an enhanced sensitivity in TNF-
a–mediated apoptosis resulting from a deficiency in Nrf2
may have suppressed the accelerating effect of lpr in
nrf2−/− lpr/lpr mice, thereby alleviating the autoimmune
disease.
Our study has shown that a deficiency in Nrf2 enhances
the sensitivity of TNF-a–mediated apoptosis through a
decrease in GSH levels. GSH is an important nonprotein
thiol molecule that protects cells against oxidative dam-
age [47, 48]. Nrf2 activates the transcription of the heavy
and light chain c-glutamylcysteine synthetase [GCS (H)
and GCS (L)] [8], and cystine membrane transporter (sys-
tem Xc−) genes [9] through an ARE/EpRE response
element [3, 4]. These molecules are necessary for the syn-
thesis of GSH [8, 9]. An inability to induce the expression
of these molecules in Nrf2-deficient mice resulted in in-
creased oxidative stress and the protective response to
electrophilic and ROS-producing agents was profoundly
impaired [9–11]. Therefore, Nrf2 deficiency resulted in
minimum levels of intracellular GSH [9].
Previous reports have shown that a preexisting re-
duction in GSH levels could significantly increase cell
death from TNF-a [49, 50], although the detailed molec-
ular mechanism remains unknown. More recently, we re-
ported that Nrf2 deficiency enhances death-inducing sig-
nals through GSH depletion [38]. In our previous study,
we found that aged Nrf2-deficient female mice developed
autoimmune glomerulonephritis probably due to an in-
crease in oxidative stress [12]. Nephritis in Nrf2-deficient
mice develops only in aged females. Therefore, it appears
that the nrf2 gene contributes to the susceptibility to au-
toimmune disease, rather than acting as an accelerating
gene for the disease. In this study, we found that Nrf2 de-
ficiency suppresses the stimulatory effects of the lpr gene,
which is well known as an accelerating gene for autoim-
mune diseases. Since this is an unexpected interaction,
it is still unclear whether Nrf2 is one of the susceptibil-
ity genes for autoimmune diseases. To elucidate the roles
of Nrf2 in the development of autoimmune diseases, we
will introduce the nrf2 mutation into BXSB/Yaa mice, a
disease model not defective for the fas gene. This should
uncover any synergistic effects that exist between the Yaa
and nrf2 mutation.
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